Assessment of Admission to the ICU of Onco-hematological Patients.

Assessment of Admission to the ICU of Onco-hematological Patients. Income Patterns and Results.

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06113601

Enrollment

800

Registered

2023-11-02

Start date

2024-01-01

Completion date

2024-09-01

Last updated

2023-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness, Hematological Diseases

Brief summary

Multicenter, observational and prospective study.

Detailed description

The data collection period will include 6 consecutive months, starting from the date of acceptance or conformity of the CEIC. Or, until an adequate sample size is reached that guarantees the statistical relevance of said analysis. All patients will subsequently be followed up 3 months after discharge from the ICU.

Interventions

OTHERThere is no intervention.

There is no intervention in the study.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Adults * Solid organ tumor or hematological malignancy,

Exclusion criteria

-under 18 years old

Design outcomes

Primary

Measure	Time frame
Hospital mortality.	During the 6 months of the study.

Contacts

Primary ContactElena Cuenca Fito

ecuencafito@gmail.com647113703

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026